When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OVID - Ovid collaborates with UConn for shRNA-based therapeutic for Angelman syndrome
Ovid Therapeutics Inc.
Ovid Therapeutics (NASDAQ:OVID)+4.7% PM, has announced a research collaboration and license agreement with University of Connecticut School of Medicine (UConn) for the development of a next-gen short hairpin RNA (shRNA) based therapeutic for Angelman syndrome.
More news on: Ovid Therapeutics Inc., Healthcare stocks news,